Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA767405 ID: 767405

Gene expression of PBMC and isolated CD4 T cells from participants in Part A REDUC clinical trial (human)

See Genome Information for Homo sapiens
REDUC Part A (NCT02092116) assessed the effect of romidepsin in ART-treated chronically HIV-1 infected individuals. More...
AccessionPRJNA767405; GEO: GSE185027
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsOriol-Tordera B et al., "Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.", EBioMedicine, 2022 Apr;78:103956
SubmissionRegistration date: 29-Sep-2021
IrsiCaixa
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments24
Publications
PubMed1
PMC1
Other datasets
BioSample24
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes3
SRA Data Details
ParameterValue
Data volume, Gbases288
Data volume, Tbytes0.11

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center